JW (Cayman) Therapeutics CoJWCTF -1.85%28 Days Inventory is 168.11 as of Dec. 2025, which is 7% above its 10-year median of 156.57. GuruFocus rates JWCTF with a GF Score™ of 28/100 and a GF Value™ of $0.57 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 638 Biotechnology companies, JW (Cayman) Therapeutics Co ranks better than 52.66% on this metric.
Inventory Turnover measures how fast the company turns over its inventory within a year.
JW (Cayman) Therapeutics Co's Inventory Turnover for the
six
months ended in Dec. 2025 was 1.09.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
JW (Cayman) Therapeutics Co's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.36.
JW (Cayman) Therapeutics Co (OTCPK:JWCTF) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
JW (Cayman) Therapeutics Co's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
JW (Cayman) Therapeutics Co's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
JW (Cayman) Therapeutics Co Days Inventory Related Terms
JW (Cayman) Therapeutics Co Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JWCTF vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, JW (Cayman) Therapeutics Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JW (Cayman) Therapeutics Co Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, JW (Cayman) Therapeutics Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where JW (Cayman) Therapeutics Co's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JW (Cayman) Therapeutics Co (JWCTF) has a Days Inventory of 168.11 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on JW (Cayman) Therapeutics Co and its competitors. This is near median its historical median of 156.57. Over the past decade, JW (Cayman) Therapeutics Co's Days Inventory has ranged from 150.88 to 271.22. According to the industry distribution chart, JW (Cayman) Therapeutics Co ranks #302 out of 638 companies in the Biotechnology industry, placing it in the top 47.3%.
Is JW (Cayman) Therapeutics Co's Days Inventory too high?
JW (Cayman) Therapeutics Co's current Days Inventory of 168.11 is near median its 10-year median of 156.57. Over the past 10 years, this metric has ranged from a low of 150.88 to a high of 271.22. The Biotechnology industry median Days Inventory is 183.88. JW (Cayman) Therapeutics Co's value of 168.11 is 8.6% below this industry median. Based on the distribution chart, JW (Cayman) Therapeutics Co ranks #302 out of 638 companies in the Biotechnology industry, which is above the industry midpoint. Overall, JW (Cayman) Therapeutics Co has a GF Score™ of 28/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does JW (Cayman) Therapeutics Co's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, JW (Cayman) Therapeutics Co ranks #302 out of 638 companies for Days Inventory. This puts JW (Cayman) Therapeutics Co in the upper half of its industry. The industry median Days Inventory is 183.88. JW (Cayman) Therapeutics Co's value of 168.11 is 8.6% below this benchmark. Historically, JW (Cayman) Therapeutics Co's own Days Inventory has ranged from 150.88 to 271.22 over the past decade. While the company's 10-year median is 156.57 vs. the industry median of 183.88, JW (Cayman) Therapeutics Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.88, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JW (Cayman) Therapeutics Co's current Days Inventory of 168.11 is 8.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on JW (Cayman) Therapeutics Co and its competitors. For the Biotechnology industry, the median Days Inventory is 183.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JW (Cayman) Therapeutics Co's current Days Inventory is 168.11, which is near median its own 10-year median of 156.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JW (Cayman) Therapeutics Co stock overvalued right now?
Based on GuruFocus' analysis, JW (Cayman) Therapeutics Co (JWCTF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.57, compared to a current price of $0.23 — trading 59.1% below its estimated fair value. The current Days Inventory is 168.11, which is near median its 10-year median of 156.57 and 8.6% below the Biotechnology industry median of 183.88. JW (Cayman) Therapeutics Co's overall GF Score™ is 28/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For JW (Cayman) Therapeutics Co (JWCTF), the current Days Inventory is 168.11 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JW (Cayman) Therapeutics Co (JWCTF) Overvalued in 2026?
Based on GuruFocus' analysis, JW (Cayman) Therapeutics Co stock appears to be undervalued.
The current stock price of $0.23 is trading 59.1% below its estimated GF Value™ of $0.57.
GuruFocus considers JW (Cayman) Therapeutics Co to be Possible Value Trap.
Key valuation signals for JWCTF:
Days Inventory: 168.11 (near median its 10-year median of 156.57)
GF Value™: $0.57 vs. price of $0.23 (59.1% below fair value)
Industry Position: 8.6% below the Biotechnology median (#302 of 638)
No single metric tells the full story. See the JWCTF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JW (Cayman) Therapeutics Co Ltd is a clinical-stage cell therapy company in China. It focuses on developing, manufacturing, and commercializing breakthrough cell-based immunotherapies for hematological cancers and solid tumors. Its lead product candidate is relmacabtagene autoleucel, which is a potential superior anti-CD19 chimeric antigen receptor T-cell (CAR-T) therapy intended for the treatment of a range of hematological cancers.
28GF Score
Get the complete analysis for JWCTF
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JWCTF has been successfully added to your 
